Stock Events

XSpray Pharma AB 

SEK77.23
0
+SEK0+0% Thursday 09:30

Statistics

Day High
77.23
Day Low
77.23
52W High
77.7
52W Low
29.39
Volume
888
Avg. Volume
473
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

21MayExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
-2.62
-1.99
-1.36
-0.73
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0GHZ.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Show more...
CEO
Dr. Per Andersson Ph.D.
Employees
23
Country
SE
ISIN
SE0009973563
WKN
000A2H48J

Listings